Solvonis Therapeutics reported that its ketamine-based treatment, SVN-001, reduced heavy drinking days by 67% compared to placebo over four months after treatment, based on a phase II trial analysis. This reduction surpasses results seen with naltrexone (Vivitrol) and GLP-1 drugs like semaglutide and pemvidutide, although the comparisons are from separate trials and patient groups. The treatment also showed significant reductions in cravings and negative thinking, with stronger effects in patients with a family history of alcohol problems. SVN-001 is now in a UK phase III trial, and the company plans to expand in Europe and advance an oral version in the US.
Solvonis Therapeutics' ketamine-based alcohol treatment shows a 67% reduction in heavy drinking days in a phase II trial, surpassing some GLP-1 drug results. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 29, 2026 14:01 WIB: of 100 priced US health stocks, 38 rose and 51 fell. Notable movers include HRTX at USD 0.28 (-4.04%), MESO at USD 14.51 (-4.03%), and CLPT at USD 15.38 (+3.71%).
Grande Portage Resources announced that the official federal permitting timetable for its New Amalga Gold Project in Southeast Alaska has been posted on the Federal Permitting Dashboard under the FAST-41 program. This milestone marks a key step in th...
The PUMP token surged 17% in 24 hours, extending its weekly gains to 38%, driven by Pump.fun's aggressive buyback program which has spent over $466 million to reduce circulating supply by nearly 17%. The platform's seven-day revenue reached $15.16 mi...
XRP's price is currently trading near $1.48, with significant institutional demand shown by $22.65 million net inflows into U.S. spot XRP ETFs on September 25, totaling about $1.79 billion cumulatively. Recent XRPL network upgrades and an upcoming Ev...
Hedera's cryptocurrency HBAR surged over 20% in 24 hours, reaching a high of $0.1306 before settling near $0.118 amid heavy trading. The price rally followed significant enterprise developments, including The Hashgraph Group's IDTrust identity platfo...
Close Brothers Group PLC shares rose nearly 11% after the company reported cost savings of £36 million for the year ending 31 July, surpassing its £25 million target. The group expects savings to exceed £60 million by the end of 2027. Despite a 17% d...
